FreeStyle Libre no Brasil: benefícios clínicos e desafios de acesso — revisão integrativa

Objectives: to analyze Brazilian evidence on the clinical benefits and quality-of-life impacts associated with FreeStyle Libre, considering recurring costs, sensor replacement, and barriers to access and education. Methods: an integrative literature review was conducted, complemented by official Brazilian documents. National studies addressing glycemic control, quality of life, diabetes education, costs, cost-effectiveness, budget impact, and incorporation into the Brazilian Unified Health System (SUS) were considered. Results: Brazilian real-world data indicate an association between more frequent use and better glycemic indicators. National studies also report favorable results in selected quality-of-life domains and suggest that diabetes education may enhance the use of the technology. However, the evidence has methodological limitations, and economic assessments indicate relevant recurring costs. CONITEC recommended against incorporating the technology into the SUS, with the decision formalized in 2025. Conclusions: FreeStyle Libre has potential clinical benefits and may improve the monitoring experience, but continued use is conditioned by costs, access, diabetes education, and sustainability.

Authors

Publication Details

Journal
Revista fisio&terapia.
Published
2026-11-14
DOI
https://doi.org/10.69849/q7rq5d71
Primary Topic
Diabetes Management and Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

FreeStyle Libre no Brasil: benefícios clínicos e desafios de acesso — revisão integrativa

Isla Rayane de Sousa Lopes, Maria Eduarda Meneses da Silva
Revista fisio&terapia.
Diabetes Management and Research
article

FreeStyle Libre no Brasil: benefícios clínicos e desafios de acesso — revisão integrativa

Isla Rayane de Sousa Lopes, Maria Eduarda Meneses da Silva
article en

Abstract

Objectives: to analyze Brazilian evidence on the clinical benefits and quality-of-life impacts associated with FreeStyle Libre, considering recurring costs, sensor replacement, and barriers to access and education. Methods: an integrative literature review was conducted, complemented by official Brazilian documents. National studies addressing glycemic control, quality of life, diabetes education, costs, cost-effectiveness, budget impact, and incorporation into the Brazilian Unified Health System (SUS) were considered. Results: Brazilian real-world data indicate an association between more frequent use and better glycemic indicators. National studies also report favorable results in selected quality-of-life domains and suggest that diabetes education may enhance the use of the technology. However, the evidence has methodological limitations, and economic assessments indicate relevant recurring costs. CONITEC recommended against incorporating the technology into the SUS, with the decision formalized in 2025. Conclusions: FreeStyle Libre has potential clinical benefits and may improve the monitoring experience, but continued use is conditioned by costs, access, diabetes education, and sustainability.

Revista fisio&terapia.Vol. 30(164)
Diabetes Management and Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon